Posatex

RSS

orbifloxacin / mometasone furoate / posaconazole

Authorised
This medicine is authorised for use in the European Union.

Overview

Posatex is a veterinary medicine used to treat dogs that suffer from acute or recurrent episodes of ear infections (otitis externa) caused by bacteria or fungi. It contains the active substances orbifloxacin, mometasone furoate and posaconazole.

This EPAR was last updated on 23/02/2021

Authorisation details

Product details
Name
Posatex
Agency product number
EMEA/V/C/000122
Active substance
  • orbifloxacin
  • Mometasone furoate
  • posaconazole
International non-proprietary name (INN) or common name
  • orbifloxacin
  • mometasone furoate
  • posaconazole
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QS02CA91
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
23/06/2008
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

14/05/2013 Posatex - EMEA/V/C/000122 - II/0028/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Otologicals

Therapeutic indication

Treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating